Sugar Supplier for Pharmaceutical Companies: Wholesale Brazilian Pharma-Grade Sucrose for Syrups, Lozenges and Oral Solid Dosage

wholesale sugar suppliers
May 2
8 min read

Wholesale Brazilian sucrose for pharmaceutical manufacturers

Pharmaceutical manufacturing places the most stringent purity, documentation, and traceability demands of any sugar end-use. We supply pharmaceutical manufacturers, syrup producers, lozenge and confectionery-pharma operations, granulation specialists, contract manufacturers (CMOs), traditional medicine and ayurvedic syrup producers, and nutraceutical brands with refined Brazilian sucrose meeting USP, BP, and European Pharmacopoeia (Ph. Eur.) compendial standards for oral pharmaceutical applications — syrups, lozenges, chewable tablets, tablet coatings, granulation, and traditional medicine preparations.

If you produce oral pharmaceuticals and need a sugar supplier with the documentation rigour, audit support, and lot-level traceability your QA team can stand behind, this page is the starting point.

Request a pharma-grade quote | ICUMSA 35 (highest purity) | ICUMSA 45

Important: scope of supply

Before going further, an honest scope statement that most commodity sugar pages avoid:

We supply refined sucrose meeting USP-NF, BP, and Ph. Eur. monographs for oral pharmaceutical applications. This includes oral liquid dosage (syrups, suspensions, elixirs), oral solid dosage (lozenges, chewable tablets, troches), tablet coatings, sugar-coated dragees, granulation processes, and traditional/herbal/ayurvedic syrup manufacture.

We do not supply low-endotoxin, pyrogen-free, or GMP-excipient-grade sucrose for parenteral (injectable), vaccine, or biopharmaceutical formulation use. That product category — sometimes called "high-purity, low-endotoxin sucrose" — is manufactured at specialised excipient facilities under different production conditions and is a different commercial market. If your application is parenteral or biopharmaceutical, you need a dedicated pharmaceutical excipient supplier, not a commodity sugar mill.

This distinction matters. Pharmaceutical procurement teams who've been promised "pharma-grade sugar" by commodity suppliers and discovered the supply doesn't meet their actual application requirements lose months of qualification work. We'd rather lose the inquiry than waste your team's time.

For the rest of the oral pharmaceutical market — which is large, global, and growing — Brazilian-origin refined sucrose with the right grade and documentation is exactly the right fit.

Why pharmaceutical sucrose is different from food-grade

The functional sweetener is the same molecule. The supplier obligations are not.

Pharmacopoeial compliance. Pharmaceutical buyers don't specify by ICUMSA — they specify by monograph. USP-NF "Sucrose" monograph, BP "Sucrose" monograph, Ph. Eur. "Saccharum" monograph. The relevant test panel goes beyond ICUMSA color and polarisation: it includes specific rotation, conductivity, dextrins, sulphur dioxide limits, residual heavy metals, microbial limits to pharmaceutical standards, and identity testing. We supply against the full applicable monograph and document accordingly.

Documentation rigour. Every consignment must arrive with a Certificate of Analysis traceable to an accredited laboratory, signed by an authorised quality representative, naming the specific test methods used (USP <841>, USP <197K>, etc.), and identifying the lot back to the producing mill and harvest period. Pharmaceutical QA teams cannot accept a generic food-grade COA.

Lot-level traceability. In a deviation event — a finished-product investigation, an out-of-specification observation, a regulatory inquiry — the sugar lot must be traceable to specific cane fields, harvest dates, mill production runs, and shipment records. Same-day root-cause investigation is the standard, not a courtesy.

Audit and qualification support. Pharmaceutical buyers will audit. First-time qualification involves documentation review, sample testing, and often a mill site visit. Recurring qualification runs annually. We provide the documentation and host audits at our partner mills with reasonable notice.

GMP context. Our partner Brazilian mills hold ISO 22000, FSSC 22000, BRCGS, and equivalent food safety credentials, with HACCP plans on file. For pharmaceutical buyers operating under cGMP regimes (FDA, EMA, MHRA, WHO-prequalified, or national equivalents), this provides the food-safety baseline; the buyer's own facility holds the GMP certification for the finished pharmaceutical product.

Grades supplied to pharmaceutical manufacturers

The right grade depends on the dosage form and the regulatory regime your finished product is sold under.

ICUMSA 35 — primary pharmaceutical grade

The strictest commercially available specification. ICUMSA color ≤35 IU, polarisation ≥99.85%, with tightened microbiological and ash limits. Used for:

Pharmaceutical syrups where colour and clarity matter (cough suppressants, paediatric formulations, OTC liquid medications)
Lozenges and chewable tablets where sugar is the bulk excipient
Sugar-coated tablet dragees and pan-coating processes
High-end traditional medicine syrups (premium ayurvedic, Unani, traditional Chinese herbal preparations)
Any application where the buyer's specification mandates ICUMSA ≤35

Specifications and applications on our ICUMSA 35 page.

ICUMSA 45 — standard pharmaceutical grade

Suitable for the majority of oral pharmaceutical applications where ICUMSA 35 is over-specified relative to the dosage form requirement. Used for:

Standard pharmaceutical syrups and elixirs
Granulation processes (wet or dry granulation where sucrose is a binder or filler)
Standard tablet coatings
General OTC liquid medications
Mid-tier traditional medicine and herbal syrup manufacture

ICUMSA 45 carries lower per-tonne cost than ICUMSA 35 and is fully compatible with most oral pharmaceutical specifications. Where contract or pharmacopoeial specification is silent on ICUMSA, ICUMSA 45 is generally the operating standard. Specifications on our ICUMSA 45 product page.

For a clean comparison of the refined grades, see ICUMSA 45 vs 100 vs 150: which grade should you buy?.

Note on ICUMSA 100 and 150: these grades are generally not appropriate for oral pharmaceutical applications. The colour, ash, and reducing sugar tolerances of ICUMSA 100/150 sit outside most USP, BP, and Ph. Eur. monograph requirements for sucrose. ICUMSA 100/150 is appropriate for non-pharma food applications; do not substitute it into pharma supply chains to save cost.

Pharmacopoeial monograph alignment

The standard monographs for sucrose used in oral pharmaceuticals are:

USP-NF "Sucrose" — United States Pharmacopeia / National Formulary
BP "Sucrose" — British Pharmacopoeia
Ph. Eur. "Saccharum" — European Pharmacopoeia (Ph. Eur. is administered by EDQM and is referenced by EMA)
JP "Sucrose" — Japanese Pharmacopoeia
IP "Sucrose" — Indian Pharmacopoeia (large practical relevance for Indian pharma manufacturers and the global ayurvedic supply chain)

Our COA panel can be issued against any of the above on request. Standard issuance covers the USP-NF / BP / Ph. Eur. trio, which together cover the majority of regulated markets. For Japanese, Indian, or Chinese Pharmacopoeia alignment, confirm at SCO stage so the producing mill issues against the correct test panel.

For broader background on quality documentation, see sugar quality certificates: how to read SGS reports, COA & lab results.

Application-by-application grade recommendation

Pharmaceutical syrups

Cough suppressants, antihistamines, paediatric formulations, OTC liquids: ICUMSA 35 strongly preferred. Colour and clarity in the finished bottle matter, especially for transparent or amber-bottle products where consumers visually evaluate the medication.

Antibiotic and prescription syrups: ICUMSA 45 acceptable where the pharmacopoeial monograph is met; ICUMSA 35 if the brand specification mandates it.

Functional ingredient delivery: ICUMSA 35 typically specified to avoid any interference with active ingredient stability or visible appearance.

Lozenges, hard-boiled medicated confectionery, troches

ICUMSA 35 is standard. The sugar is essentially the dosage form here — it makes up the majority of the product mass, and any colour or impurity is directly visible in the finished lozenge.

Tablet coatings and sugar-coated dragees

ICUMSA 35 for visible coating layers; ICUMSA 45 acceptable for sub-coats and seal-coats where surface appearance is determined by the final finishing layer.

Wet and dry granulation

ICUMSA 45 typically sufficient for granulation as a binder or filler. The sugar is integrated into a tablet matrix that is then film-coated, so visible appearance of the sugar input does not transfer to the final product.

Traditional medicine syrups (ayurvedic, Unani, TCM, herbal)

ICUMSA 35 for premium-positioned brands and for products exported to regulated markets. ICUMSA 45 for domestic-market syrups in markets without strict cosmetic colour requirements. Note: ayurvedic syrups historically use significantly more sugar per dose than Western pharma syrups; volume requirements per finished-unit are correspondingly higher, which makes the price difference between grades commercially material.

Nutraceutical and supplement syrups

ICUMSA 45 generally sufficient. Where the product is positioned as "pharmaceutical quality" or carries cGMP claims, buyers often specify ICUMSA 35 for marketing-credibility reasons even where the pharmacopoeial monograph does not technically require it.

Documentation pack on every shipment

Every pharmaceutical-bound consignment ships with:

Certificate of Analysis issued by the producing mill or accredited laboratory, with the full pharmacopoeial test panel for the specified monograph (USP-NF / BP / Ph. Eur. / others as required), naming the test methods used, signed by an authorised quality representative
SGS pre-shipment inspection certificate (or Bureau Veritas / Intertek where contractually preferred), independently verifying quantity and conformance
Mill GMP / food safety certifications — ISO 22000, FSSC 22000, BRCGS, or equivalents on file with current validity
HACCP plan documentation available for buyer audit
Lot traceability documentation linking the consignment to specific mill production lots, harvest periods, and (where buyer requires) cane sourcing zones
Commercial Invoice and Packing List with lot numbers cross-referenced to the COA
Bill of Lading (Original 3/3 set)
Certificate of Origin issued by the Brazilian Chamber of Commerce
Phytosanitary Certificate issued by MAPA (Brazilian Ministry of Agriculture)
Halal certification where required by the buyer's onward market
Kosher certification where required for Jewish-market or US OTC supply
Vegetarian/vegan declarations where required
Heavy metals testing report (lead, mercury, arsenic, cadmium) where the buyer's pharmacopoeial alignment requires it
Microbial limits report to pharmaceutical standards (not just food-grade)

Audit, qualification and approved-vendor processes

Pharmaceutical buyers audit. We support that.

First-time qualification. Documentation pack review (mill credentials, food safety system, COA history, sample COA against the buyer's pharmacopoeial requirement), sample qualification (typically a 50–500kg representative sample for the buyer's QC lab to test against incoming-quality protocols), and where required, a mill site visit. Site visits and third-party audits hosted at our partner mills with reasonable notice.

Annual or recurring requalification. Refreshed documentation pack, COA performance review, any changes to the mill's certification status flagged proactively, and renewed sample testing where the buyer's protocol requires.

Change control. If the producing mill changes (e.g., a contracted mill reaches capacity and supply is reallocated), this is communicated in advance with new documentation, not after the fact. Pharmaceutical QA teams need supplier change information for their own change-control processes.

Deviation response. In the event of a specification non-conformance, root cause investigation is initiated within 24 hours, lot-level isolation is provided, and a CAPA report is issued within agreed timelines.

For the underlying mill audit framework, see certifications for Brazilian sugar sourcing.

Volume tiers and supply structures

Spot orders — 135 MT to 1,000 MT. Suitable for smaller pharmaceutical operations, contract manufacturers running specific batches, or first-time qualification before contract supply. 50kg PP bags. Lead time 30–45 days from operative LC.

Mid-volume orders — 1,000 MT to 12,500 MT. Quarterly or monthly nominations against a standing contract. Suitable for mid-size pharmaceutical operations and CMOs with regular production schedules. Pricing typically structured against ICE No.5 White Sugar Futures plus a fixed differential.

Annual offtake contracts — 12,500 MT and above. For large pharmaceutical groups, ayurvedic and traditional medicine producers, and contract manufacturers serving global brands. 12-month volume commitments with monthly nominations, fixed or floating pricing, and stable mill assignment for documentation continuity.

Specialty packaging. Pharmaceutical buyers often require packaging beyond standard 50kg PP bags — tamper-evident seals, double-bagged inner liners for cleanroom decanting, smaller 25kg pack sizes for pilot-scale production. Confirm specifications at SCO stage.

For pricing context, see wholesale sugar prices, sugar futures NY11 explained, and sugar market forecast 2026. For Incoterms mechanics, see FOB vs CIF sugar pricing.

How to start pharmaceutical-grade supply

The first-shipment journey for pharmaceutical buyers:

Submit an inquiry through our contact page with: company name, country and target regulatory regime (FDA / EMA / MHRA / national equivalent), target grade (ICUMSA 35 or 45), pharmacopoeial monograph required (USP-NF, BP, Ph. Eur., JP, IP), application (syrup, lozenge, granulation, etc.), volume per shipment or annual offtake estimate, packaging requirements, and any specific test methods or tolerances beyond the standard monograph panel.
Receive a Soft Corporate Offer (SCO) with FOB Santos and CIF [your port] pricing, mill source, lead time, full specification commitment, and documentation pack outline.
Documentation pack review by your QA team. Mill credentials, sample COA against your pharmacopoeial requirement, food safety certifications, HACCP documentation.
Sample qualification. A representative sample shipped under expedited terms for your QC lab to test against incoming-quality protocols and pharmacopoeial monograph.
Mill audit (where required). Buyer or third-party audit of the producing mill. Hosted with reasonable notice.
Contract negotiation and signature. ICPO and BCL from buyer; draft SPA from us; both parties countersign.
Operative LC opening and shipment. Lead time 30–45 days from operative LC for first shipment.

Total time from initial inquiry to first cargo at the buyer's facility: typically 90–120 days for first shipment with full pharmaceutical qualification, faster for repeat orders under standing contracts.

For the broader buyer process, see how to import sugar from Brazil. For the trade documents involved, see sugar trade documents explained: ICPO, BCL, LOI, SPA & SCO. For payment mechanics, see letter of credit for sugar imports.

Get a quote for pharmaceutical-grade supply

Tell us your application, target grade, pharmacopoeial requirement, annual volume, and current supplier situation, and we'll send back an indicative SCO within 48 hours, plus a documentation pack you can run through your QA qualification process.

If you're switching from an incumbent supplier and want to qualify us in parallel before committing, we can structure a single-container trial order against your existing specifications and pharmacopoeial requirements.